Indo-Bangla Pharmaceuticals Limited (DSE: IBP)
Health Care · Pharmaceuticals · BD
Tk17.30
-10.82% today · +33.1% 1Y
Indo-Bangla Pharmaceuticals Limited (DSE: IBP) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $16.43M.
Over the last twelve months the share price has gained 33.1%, trading between 10.00 and 21.40.
Tweenvest scores Indo-Bangla Pharmaceuticals Limited across four factors: quality 64/100, value 54/100, growth 0/100, dividend 9/100. Its strongest factor is quality.
IBP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $16.43M
- Revenue (TTM)
- $1.97M
- P/E
- —
- EPS
- -0.12
- Dividend yield
- 0.09%
- Beta (5Y)
- 0.20
- 52-week high
- Tk21.40
- 52-week low
- Tk10.00
- Avg volume (3M)
- —
- Shares outstanding
- 116.21M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,256.27 | +0.75% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $272.69 | -0.13% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $153.63 | +1.97% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.60 | +0.86% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £123.85 | +2.27% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.45 | +1.72% |
Figures last refreshed Aug 18, 2026.